Avantax Advisory Services’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Buy |
111,176
+2,849
| +3% | +$51.9K | 0.01% | 793 |
|
|
2025
Q1 | $2.15M | Buy |
108,327
+1,954
| +2% | +$38.8K | 0.01% | 703 |
|
|
2024
Q4 | $1.82M | Buy |
106,373
+8,109
| +8% | +$139K | 0.01% | 752 |
|
|
2024
Q3 | $1.96M | Sell |
98,264
-7,889
| -7% | -$158K | 0.01% | 706 |
|
|
2024
Q2 | $1.19M | Buy |
106,153
+183
| +0.2% | +$2.05K | 0.01% | 893 |
|
|
2024
Q1 | $699K | Hold |
105,970
| – | – | 0.01% | 895 |
|
|
2023
Q4 | $479K | Hold |
105,970
| – | – | ﹤0.01% | 1008 |
|
|
2023
Q3 | $379K | Sell |
105,970
-650
| -0.6% | -$2.33K | ﹤0.01% | 1065 |
|
|
2023
Q2 | $393K | Sell |
106,620
-7,000
| -6% | -$25.8K | ﹤0.01% | 1045 |
|
|
2023
Q1 | $376K | Sell |
113,620
-13,500
| -11% | -$44.7K | ﹤0.01% | 1032 |
|
|
2022
Q4 | $493K | Hold |
127,120
| – | – | 0.01% | 872 |
|
|
2022
Q3 | $309K | Hold |
127,120
| – | – | ﹤0.01% | 991 |
|
|
2022
Q2 | $252K | Hold |
127,120
| – | – | ﹤0.01% | 1092 |
|
|
2022
Q1 | $233K | Hold |
127,120
| – | – | ﹤0.01% | 1120 |
|
|
2021
Q4 | $179K | Buy |
127,120
+55,000
| +76% | +$77.4K | ﹤0.01% | 1183 |
|
|
2021
Q3 | $81K | Sell |
72,120
-74,710
| -51% | -$83.9K | ﹤0.01% | 1153 |
|
|
2021
Q2 | $235K | Sell |
146,830
-40
| -0% | -$64 | ﹤0.01% | 1003 |
|
|
2021
Q1 | $260K | Buy |
146,870
+35,000
| +31% | +$62K | 0.01% | 868 |
|
|
2020
Q4 | $219K | Sell |
111,870
-47,500
| -30% | -$93K | 0.01% | 848 |
|
|
2020
Q3 | $383K | Buy |
159,370
+7,320
| +5% | +$17.6K | 0.01% | 909 |
|
|
2020
Q2 | $445K | Sell |
152,050
-20,000
| -12% | -$58.5K | 0.01% | 510 |
|
|
2020
Q1 | $495K | Buy |
172,050
+37,000
| +27% | +$106K | 0.01% | 437 |
|
|
2019
Q4 | $540K | Hold |
135,050
| – | – | 0.01% | 448 |
|
|
2019
Q3 | $601K | Hold |
135,050
| – | – | 0.02% | 289 |
|
|
2019
Q2 | $523K | Buy |
135,050
+35,000
| +35% | +$136K | 0.02% | 287 |
|
|
2019
Q1 | $379K | Buy |
100,050
+35,000
| +54% | +$133K | 0.02% | 313 |
|
|
2018
Q4 | $156K | Buy |
+65,050
| New | +$156K | 0.03% | 388 |
|